anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

220,741-220,800 of 319,975

filter-aware
04
Uses an analogy to establish market positioning.Freightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations 1 hit
05
Freightos | Investor Presentation Deck | 34 slidesFreightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations 1 hit
06
Uses a value-chain style diagram to show the complexity and manual communication flow.Freightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
The slide uses a hub-and-spoke style diagram overlaid on a world map to connect specific industry pain points to the global supply chain.Freightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
08
Uses a funnel-like decomposition to isolate a specific addressable market segment.Freightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations Beat · Market Size1 hit
09
Uses a chronological progression framework to position the company as the current evolution of platform business models.Freightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations Beat · Market Size1 hit
10
Uses travel industry analogies (Amadeus/Sabre and Booking.com/Expedia) to explain the business model.Freightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations Beat · Solution1 hit
11
Freightos | Investor Presentation Deck | 34 slidesFreightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations 1 hit
12
The chart uses a trend line to emphasize the growth trajectory.Freightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations Beat · Traction1 hit
13
Freightos | Investor Presentation Deck | 34 slidesFreightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations Beat · Traction1 hit
14
Freightos | Investor Presentation Deck | 34 slidesFreightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations Beat · Traction1 hit
15
Includes logos for CME Group and SGX as partners/integrators.Freightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations Beat · Traction1 hit
16
Freightos | Investor Presentation Deck | 34 slidesFreightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations Beat · Traction1 hit
17
The chart tracks the Q3 2021 cohort's transaction volume as a percentage of their initial booking volume in the first quarter.Freightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations Beat · Traction1 hit
18
Freightos | Investor Presentation Deck | 34 slidesFreightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations Beat · Financials1 hit
19
The slide uses a flywheel concept to frame the growth metrics.Freightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations Beat · Financials1 hit
20
The slide illustrates the dual revenue stream model of the company.Freightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations Beat · Financials1 hit
21
The slide uses a combination of a grouped bar chart for internal performance and a single bar chart for peer benchmarking.Freightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations Beat · Financials1 hit
22
Freightos | Investor Presentation Deck | 34 slidesFreightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations Beat · Financials1 hit
23
The table includes metrics for transactions, GBV, revenue, and adjusted EBITDA with year-over-year growth projections.Freightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations Beat · Financials1 hit
24
Freightos | Investor Presentation Deck | 34 slidesFreightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations Beat · Financials1 hit
25
This is a closing slide for an investor presentation.Freightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
26
Freightos | Investor Presentation Deck | 34 slidesFreightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations 1 hit
27
Freightos | Investor Presentation Deck | 34 slidesFreightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations 1 hit
28
The table includes a specific line item for 'Share listing expense' which is footnoted as a non-recurring, non-cash expense.Freightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations 1 hit
29
The table provides a clear bridge between GAAP/IFRS operating loss and non-GAAP Adjusted EBITDA metrics.Freightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations 1 hit
30
The table shows adjustments for share-based compensation and depreciation & amortization to arrive at non-IFRS metrics.Freightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations 1 hit
31
Freightos | Investor Presentation Deck | 34 slidesFreightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations 1 hit
32
The table shows adjustments for share-based compensation and depreciation & amortization.Freightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations 1 hit
33
Freightos | Investor Presentation Deck | 34 slidesFreightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations 1 hit
34
Freightos | Investor Presentation Deck | 34 slidesFreightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations 1 hit
01
Slide 1
Freyr | Results Presentation Deck | 14 slidesFreyr | Results Presentation Deck | 14 slides · FREYR
Conference presentation Investor relations 1 hit
02
Freyr | Results Presentation Deck | 14 slidesFreyr | Results Presentation Deck | 14 slides · FREYR
Conference presentation Investor relations 1 hit
03
The slide uses a five-column layout to present key investment pillars.Freyr | Results Presentation Deck | 14 slides · FREYR
Conference presentation Investor relations Beat · Problem1 hit
04
The slide title mentions 4 key messages, but only 2 are presented on this page.Freyr | Results Presentation Deck | 14 slides · FREYR
Conference presentation Investor relations Beat · Problem1 hit
05
Freyr | Results Presentation Deck | 14 slidesFreyr | Results Presentation Deck | 14 slides · FREYR
Conference presentation Investor relations Beat · Problem1 hit
06
Freyr | Results Presentation Deck | 14 slidesFreyr | Results Presentation Deck | 14 slides · FREYR
Conference presentation Investor relations Beat · Solution1 hit
07
Freyr | Results Presentation Deck | 14 slidesFreyr | Results Presentation Deck | 14 slides · FREYR
Conference presentation Investor relations Beat · Solution1 hit
08
The slide uses a structured approach to justify a capital allocation decision based on external regulatory environments.Freyr | Results Presentation Deck | 14 slides · FREYR
Conference presentation Investor relations Beat · SolutionLoop · Why Now1 hit
09
CQP likely refers to Customer Qualification Process; FID refers to Final Investment Decision; SOP refers to Start of Production.Freyr | Results Presentation Deck | 14 slides · FREYR
Conference presentation Investor relations Beat · SolutionLoop · Why Now1 hit
10
The slide uses a two-column layout to contrast the 'why' (rationale) and the 'how/when' (status) of a corporate action.Freyr | Results Presentation Deck | 14 slides · FREYR
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
11
The slide uses a waterfall chart to explain the cash position change.Freyr | Results Presentation Deck | 14 slides · FREYR
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
12
Freyr | Results Presentation Deck | 14 slidesFreyr | Results Presentation Deck | 14 slides · FREYR
Conference presentation Investor relations Beat · Financials1 hit
13
Freyr | Results Presentation Deck | 14 slidesFreyr | Results Presentation Deck | 14 slides · FREYR
Conference presentation Investor relations Beat · The Ask1 hit
14
Freyr | Results Presentation Deck | 14 slidesFreyr | Results Presentation Deck | 14 slides · FREYR
Conference presentation Investor relations Beat · The Ask1 hit
01
Slide 1
Fusion Pharmaceuticals | Investor Presentation Deck | 30 slidesFusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
02
Fusion Pharmaceuticals | Investor Presentation Deck | 30 slidesFusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
03
The slide uses a combination of bulleted benefits and a visual process diagram to explain the mechanism of action.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · ProblemLoop · Why Now1 hit
04
The slide uses a linear process flow to highlight competitive differentiation.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · ProblemLoop · Why Now1 hit
05
The slide uses a Gantt-style visualization to represent drug development stages.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · ProblemLoop · Why Now1 hit
06
The slide emphasizes vertical integration and strategic supply agreements as a moat.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
07
Includes a logo grid of previous affiliations at the bottom.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
08
Fusion Pharmaceuticals | Investor Presentation Deck | 30 slidesFusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
09
Includes a visual case study (Subject #4) showing PET scan response.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
10
Includes a clinical case study image showing patient response to therapy.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Market Opportunity1 hit
11
The slide illustrates the transition from a 177Lu-based molecule (IPN-1087) to a 225Ac-based molecule (FPI-2059) to improve efficacy.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Market Opportunity1 hit
12
The slide outlines a standard clinical trial dose escalation design (3+3) for a radiopharmaceutical.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Market Opportunity1 hit
13
Fusion Pharmaceuticals | Investor Presentation Deck | 30 slidesFusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
14
The slide contrasts a chemotherapy-based approach (SMDC) with a radioligand therapy (RLT) approach, highlighting the superior PSA response in the RLT cohort.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
15
The slide uses a PET scan image to demonstrate selective tumor uptake versus normal tissue, and a table to quantify market opportunity by tumor type.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit